This Week in Chancery Court: Biogen, T-Mobile, Repsol SA

Biogen Inc. is fending off a lawsuit in the Delaware Chancery Court over its recent offer to buy out Sage Therapeutics, its collaborator on a postpartum depression drug.

Here’s what else is on the Chancery Court and Delaware Supreme Court calendars:

Monday: In re New Relic Inc., Del. Ch., No. 2023-1089, oral arguments 1/27/25.

At issue: Chancellor Kathaleen St. Jude McCormick will review a pension fund’s exceptions to a ruling determining that personal emails from New Relic Inc. founder and former CEO Lew Cirne are protected from a shareholder investigation into the cloud analytics company’s $6.5 billion take-private ...